Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 17/20 | 0.59 |
| ▸ | SLC5A1 | P13866 | 10/20 | 0.59 |
| ▸ | PDE2A | O00408 | 2/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17859644 | 1.00 | SLC5A2 (0.59) | SLC5A2SLC5A1PDE2APDE10AHRH3 | |
| SCHEMBL17189332 | 0.88 | SLC5A2 (0.59) | SLC5A2SLC5A1PDE2APDE10A | |
| SCHEMBL14949125 | 0.88 | SLC5A2 (0.46) | SLC5A2SLC5A1HRH3 | |
| SCHEMBL15682904 | 0.88 | SLC5A2 (0.46) | SLC5A2SLC5A1HRH3 | |
| SCHEMBL30830341 | 0.88 | SLC5A2 (0.61) | SLC5A2SLC5A1PDE2APDE10AHRH3 | |
| SCHEMBL14949153 | 0.88 | SLC5A2 (0.46) | SLC5A2SLC5A1HRH3 | |
| SCHEMBL19189964 | 0.87 | SLC5A2 (0.60) | SLC5A2SLC5A1PDE2APDE10AHRH3 | |
| SCHEMBL28981278 | 0.86 | SLC5A2 (0.57) | SLC5A2SLC5A1PDE2APDE10A | |
| SCHEMBL28981279 | 0.86 | SLC5A2 (0.57) | SLC5A2SLC5A1PDE2APDE10A | |
| SCHEMBL3465613 | 0.86 | SLC5A2 (0.59) | SLC5A2SLC5A1PDE2APDE10AHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3246324-A2 | PHENYL C-GLUCOSIDE DERIVATIVE CONTAINING DEOXYGLUCOSE STRUCTURE, PREPARATION METHOD AND USES THEREOF | Tianjin Institute Of Pharmaceutical Research (CN) | 2017-11-22 | — | — | EP | disclosed |
| EP-2776449-B1 | PROCESS FOR THE PREPARATION OF BETA-C-ARYL GLUCOSIDES | SCINOPHARM TAIWAN LTD (TW) | 2017-08-02 | — | — | EP | disclosed |
| US-20170057989-A1 | PHENYL C-GLUCOSIDE DERIVATIVE CONTAINING DEOXYGLUCOSE STRUCTURE, PREPARATION METHOD AND USE THEREOF | TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) | 2017-03-02 | — | — | US | disclosed |
| US-9505734-B2 | Phenyl C-glucoside derivative containing deoxyglucose structure, preparation method and use thereof | TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) | 2016-11-29 | — | — | US | disclosed |
| EP-2933250-A1 | PHENYL C-GLUCOSIDE DERIVATIVE CONTAINING DEOXYGLUCOSE STRUCTURE, PREPARATION METHOD AND USE THEREOF | Tianjin Institute Of Pharmaceutical Research (CN) | 2015-10-21 | — | — | EP | disclosed |
| US-8802842-B2 | Method for the preparation of a crystalline form | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-08-12 | — | — | US | disclosed |
| WO-2013068850-A2 | PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES | SCINOPHARM TAIWAN, LTD. (NA) | 2013-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170057989-A1 | PHENYL C-GLUCOSIDE DERIVATIVE CONTAINING DEOXYGLUCOSE STRUCTURE, PREPARATION METHOD AND USE THEREOF | GCG, SLC5A1, DPP7 | SLC5A2 6/4885SLC5A1 2/4885PDE2A 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.